Catheter for the transvascular implantation of prosthetic heart valves

Information

  • Patent Grant
  • 8679174
  • Patent Number
    8,679,174
  • Date Filed
    Thursday, January 12, 2006
    19 years ago
  • Date Issued
    Tuesday, March 25, 2014
    10 years ago
Abstract
A catheter for the transvascular implantation of prosthetic heart valves, including self-expanding anchorage supports, which allow a minimally invasive implantation of prosthetic heart valves to reduce the risk to the patient during the implantation. A prosthetic heart valve including anchorage supports is temporarily housed in a folded form in a cartridge-type unit during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system, which includes a flexible region that can be guided through the aorta. Actuating elements run through the interior of the hollow guide system, permitting sections of the cartridge-type unit to be displaced radially about their longitudinal axis and/or laterally in a proximal direction, thus allowing individual sections of the anchorage support and the associated prosthetic heart valve to be sequentially released.
Description

The invention relates to catheters for the transvascular implantation of prosthetic heart valves with self-expanding anchoring systems, by means of which prosthetic heart valves can be implanted with minimal invasion.


It is becoming more frequently necessary for an increasing number of patients to have prosthetic heart valves implanted, for which purpose both artificial and biological implants are used for heart valve prostheses.


In the past, such operations have been conducted in such a way that it as necessary to use a heart-lung machine on the anaesthetised patient. This therefore makes it a cost-intensive surgical intervention, which subjects the respective patients to a high degree of psychological and physical stress. The aim is to keep the lethality risk below 3%. As the age of the respective patients increases and impairment of the respective heart valves becomes more advanced, a situation is reached in which patients in need of actual treatment become inoperable. Since surgical valve replacement is not possible for these patients, they suffer from a reduce quality of life and have a considerably reduced life expectancy. Intervention would pose an extremely high risk.


These same issues also apply to operations whereby prosthetic heart valves with anchoring systems are implanted by means of so-called balloon catheters.


In a procedure of this type, incorrect positioning can occur, which can have considerable consequences for the patient, possibly leading to the death of the respective patient.


In recent times, therefore, attempts have been made to implant heart valve prostheses by means of intervention methods involving minimal invasion, whereby such prostheses are fed together with an anchoring support via the aorta of a patient and through the aorta to the heart. On reaching the implantation site at the heart, self-expansion of such anchoring supports with a heart valve prosthesis attached to them is initiated, the intended result being a reliable anchoring and exact positioning of the heart valve prosthesis. Such anchoring supports have tended to be made from shape memory alloys, such as “Nitinol” for example, and the alloy is selected so that its transition temperature is around 37° C., and self-expansion can be initiated on reaching the transition temperature.


As a result of such expansion, the anchoring support opens up so that it is able to lie against the aorta wall, where it can be securely fixed by means of additional barb elements if necessary. The heart valve prosthesis is folded open simultaneously, so that it is able to assume its function.


An anchoring support of this type incorporating a heart valve prosthesis is described in patent specification WO 2004/019825 A1, for example.


Support hoops are provided at the proximal end of such an anchoring support, which can be introduced into the pockets of a patient's heart valve, thereby enabling the anchoring support to be very accurately positioned by means of these support hoops during a surgical intervention. What are referred to as commissural hoops are provided on this anchoring support in addition, which, together with the support hoops, clamp parts of a patient's old heart valve once the anchoring support has unfolded so that the anchoring support can be reliably positioned and secured as a result of this clamping effect.


The support and commissural hoops of this known anchoring support should therefore be disposed and dimensioned so that they permit a sequential self-expansion. This means that the anchoring support is accommodated inside a cartridge for the implantation procedure. It is then fed by means of a catheter through the aorta as far as the diseased heart. On reaching the implantation site, the cartridge is manipulated so that the support hoops are released to allow them to self-expand. The cartridge is then moved and oriented together with the anchoring support so that the support hoops are introduced into the pockets of the heart valve of the respective patient. This enables exact positioning to be achieved.


The respective cartridge is then further manipulated, so that the commissural hoops are also released and able to self-expand. As this happens, the old heart valve is clamped between the support and commissural hoops and the heart valve prosthesis is opened-up into its unfolded functional position.


After implanting the anchoring support incorporating the heart valve prosthesis, the catheter can then be removed from the patient's body together with the cartridge through the aorta.


Although the support hoops provided on the anchoring support can result in significantly easier and better positioning of the heart valve prosthesis to be implanted in the manner described above, there is a possibility of incorrect implantation and the heart valve prosthesis may not be capable of functioning or may be so to only an unsatisfactory degree. In certain situations, it is then no longer possible to remove a non-functioning or unsatisfactorily functioning heart valve prosthesis and it poses an increased risk of mortality for the respective patient in some cases.


The bend in the aorta in the human body during introduction through the aorta poses another problem during such surgical interventions. As the cartridge and the respective catheter are moved during this procedure, a change of direction of approximately 18° with a relatively small radius of about 50 mm has to be negotiated without causing damage to the vessel wall.


Accordingly, the objective of the invention is to reduce risk to the patient during implantation of prosthetic heart valves.


This objective is achieved by the invention on the basis of a catheter incorporating the characterising features defined in claim 1. Advantageous embodiments and designs of the invention may be obtained on the basis of the characterising features defined in the dependent claims.


In a preferred embodiment, a catheter proposed by the invention may be used in conjunction with a heart valve prosthesis with a self-expanding anchoring support of the type known from patent specification WO 2004/019825 and the disclosed contents are included herein by way of reference.


This being the case, the anchoring support with the heart valve prosthesis attached to it can be temporarily accommodated inside a cartridge unit in a collapsed state during the implantation.


A cartridge unit prepared in this manner can be releasably attached to the proximal end of a guide system. The cartridge unit and guide system are minimised in term of their external diameter to the degree that they can be fed through an aorta of a patient to be operated on without any difficulty, and to this end, the total free cross-section available inside the aorta should not be completely filled.


The guide system used is sufficiently long in terms of its length for the cartridge unit to be fed with the guide system by introducing it into the groin of a patient, through the aorta as far as the patient's heart.


A flexible, bendable region is provided on the guide system, by means of which a bending radius and bending angle can be achieved that will follow and make allowance for the bend in the patient's aorta.


Elements for operating the cartridge unit are fed by means of the guide system, which has a hollow interior. These operating elements enable parts of the cartridge unit to be manipulated and moved in a specific way. For example, a radial or also lateral movement of parts of the cartridge unit can be effected by means of the operating elements. Moving parts of the cartridge unit in this specific way enables parts of the anchoring support to be released in sequence so that implantation and anchoring can take place in the manner described in WO 2004/019825.


For example, support hoops of an anchoring support can be released by a rotation or by a lateral movement in the proximal or distal direction of a part of the cartridge unit, but other parts, such as the commissural hoops for example, continue to be retained inside the cartridge unit in the collapsed state, which can subsequently be released with a view to expansion by moving another part of the cartridge unit accordingly or by continuing the movement of the same part of the cartridge unit which previously still enabled the support hoops to be retained inside the cartridge unit in the collapsed state.


The heart valve prosthesis, which is attached to the anchoring support by stitching for example, opens simultaneously as the respective hoops of the anchoring support, to which the heart valve prosthesis is attached, expand.


In a preferred embodiment, in addition to the operating elements for parts of the cartridge unit, other operating elements are fed through the internally hollow guide system, which act on the bendable region in order to influence its curvature in a specific manner.


Due in particular to traction forces triggered via the operating elements, a specific curvature of the bendable region can be achieved during the implantation on penetrating the bend of the aorta. Tension cables or tension wires may be used as the operating elements, which are run through the internally hollow guide system as far as the proximal edge of the bendable region, where they are secured on the guide system, in which case the attacking points of the force of two such operating elements should be disposed diametrically opposite one another and in addition should be disposed at 90° with respect to the bending axis about which the bendable region is required to curve.


For example, the curvature of the bendable region can be influenced in a specific way by applying a traction force via one of the operating elements as the guide system is pushed through the bend in the aorta by means of the bendable region and pulled out of it once the implantation has been completed.


The bendable region of a guide system may be provided in the form of a link chain, in which the individual links are connected to one another by individual joints. This being the case, the individual joints positively engage in respective adjacent links. They are designed so that a curvature of more than 180° can be maintained in the bending region, with a bending radius which guarantees that at least the radius of the bend in the aorta can be achieved.


The individual joints on the individual links of a link chain should also be disposed diametrically opposite one another in pairs on the individual links and parallel with the rotation axis of the bendable region.


The guide system used with a catheter proposed by the invention should advantageously also be designed so that a liquid coolant or a pharmaceutical preparation can be circulated through the internally hollow guide system as far as the cartridge unit. With the aid of such a liquid coolant, for example a salt solution, the anchoring support can be kept below the transition temperature of the shape memory alloy. This also prevents body fluids from being able to penetrate the interior of the guide system and a liquid pressure should therefore be maintained which lends a sufficiently high resistance to penetration by body fluid or other elements contained in body fluid.


Introducing liquid coolant in an appropriate manner can also prevent gas, for example air, from getting into the aorta and the blood.


To this end, the entire guide system should be as liquid-proof as possible. Accordingly, a flexible, bendable region provided in the form of a link chain in this instance may be sealed from the outside by means of a plastic hose to render it liquid-proof.


The parts of the cartridge unit which can be moved in a specific way in order to release hoops of the anchoring support are preferably provided in the form of sleeve-shaped elements, the internal and external diameters of which are adapted to one another so that they can engage in one another telescopically, and at least two of the sleeve-shaped elements have mutually adapted internal and external diameters such that a collapsed anchoring support with heart valve prosthesis can be accommodated between them and retained in the collapsed state.


When introducing the catheter, the cartridge unit should be completely closed as far as possible and to facilitate introduction through the aorta should have a tip at its proximal end, which is in turn preferably made from a flexible material, for example silicone.


When the cartridge unit reaches the respective patient's heart, the appropriate manipulation can then be performed, in other words parts/sleeve-shaped elements of the cartridge unit moved, so that the different hoops of the anchoring support are sequentially released and the heart valve prosthesis secured to them simultaneously opened up.


As this happens, however, the anchoring support is still securely retained on the cartridge unit. To this end, anchoring elements are provided on one sleeve-shaped element of the cartridge unit, disposed at the distal end, for example at a point where eyes are provided on the anchoring support. In this position, these anchoring elements together with the distal part of the anchoring support are also covered by a sleeve-shaped element of the cartridge unit, so that the distal part of the anchoring element is still retained in the collapsed state.


In this position, it is possible to check the function of the heart valve prosthesis, which has already unfolded. Once it is evident that the heart valve prosthesis is functioning, a further manipulation may be effected by moving the sleeve element that was previously covering the anchoring element with the distal part of the anchoring support accordingly, which causes the distal part of the anchoring support to be fully released as well so that it can then fully unfold.


If, on checking, it is found that the implanted heart valve prosthesis is not fulfilling its function or is so but not satisfactorily, it is advantageously possible to move the anchoring support together with the heart valve prosthesis back into the cartridge unit by moving the parts/sleeve-shaped elements in the opposite direction accordingly and removing all the parts, in other words the entire catheter, from the patient's body again, thereby significantly reducing the risk of the operation, after which a further attempt at implantation can be made on the same patient.


In one advantageous embodiment of the catheter proposed by the invention, a guide wire can also be run through the entire catheter. Such guide wires are already used for operations of this type and they are fed through the patient's aorta to a point behind the heart before introducing the catheter. The catheter can then be placed over the cartridge unit and guide system and into the guide wire and pushed in along it into the aorta as far as the patient's heart.


In order to monitor the process of introducing the catheter and also manipulation of the bendable region, in particular at the bend of the aorta, it is of advantage to provide marker elements on the guide system and/or the cartridge unit, made from a material which absorbs X-radiation, so that the respective position can be pinpointed on an X-ray image during the operation.


A screen filter may also be used with the catheter proposed by the invention, by means of which particles can be prevented from penetrating the respective patient's blood circulation system. Such a screen filter may be attached to the guide system so that it completely surrounds it in the radial direction. In this respect, it should be elastically biased so that it lies against the vessel wall of the aorta, thereby guaranteeing a closure that is impermeable to particles.


Furthermore, the catheter proposed by the invention may additionally be provided with a conventional balloon disposed in the interior of the guide system or cartridge unit and carried with it there or alternatively it can be fed through the interior of the guide system as far as the anchoring support to be expanded. Using such a balloon, the volume of which can be increased by means of a fluid at increased pressure, will further assist expansion of the anchoring support.


The operating elements described above, which may be fed through the interior of the guide system and provided in the form of traction and compression means, may advantageously be manipulated from a manipulating part. The manipulating part may be designed as a handle, by means of which the movement for introducing the catheter can then be effected by the respective surgeon.


Other control elements are also provided on such a manipulating part, by means of which the respective movement of the operating elements can be initiated. This being the case, it should be possible to effect the corresponding movement in as measured a manner as possible, for example with appropriate translation ratios, and it should be possible to restrict the respective movement by end stops or catch positions at least. This enables specific maximum distances or angles to be preserved, for which allowance can be made in achieving the sequential expansion of the anchoring support or the specific way in which the curvature of the bendable region is influenced. In this respect, it should be possible to adjust the end stops or individual catches as finely as possible.


All the parts of a catheter proposed by the invention but at least those which come into direct contact with the respective patient and are also introduced into the aorta should be made from bio-compatible materials which are compatible with the respective organism. It should also be possible to sterilise them, in which case it should be possible to use one of the standard sterilisation processes.


The invention will be explained in more detail on the basis of examples.





Of the drawings:



FIGS. 1 to 4 are schematic diagrams illustrating an example of a catheter proposed by the invention during different possible phases of an implantation procedure;



FIG. 5 shows an example of a catheter with a manipulating part and



FIG. 6 is an exploded diagram illustrating the manipulating part illustrated in FIG. 5.






FIGS. 1 to 4 are intended to illustrate and provide a clearer understanding of an example of a catheter proposed by the invention. The individual diagrams illustrate different phases which take place during implantation of an anchoring support 10 incorporating a heart valve prosthesis.


The example of a catheter proposed by the invention illustrated in FIG. 1 is shown with the cartridge unit 4, which is still completely closed, containing an anchoring support 10 incorporating a heart valve prosthesis in the non-expanded state and thus collapsed, so that it can be fed by means of the internally hollow guide system 1 through an appropriate access into the aorta and through it to the respective implantation site on the patient's heart.


Proximally disposed on the cartridge unit 4 is a flexible tip made from silicone, which facilitates the introduction procedure and reduces the risk of damage.


Part 5 of the cartridge unit is releasably connected to the other parts of the guide system 1, for example by means of a screw connection.


Adjoining the cartridge unit 4 is a bendable region 9, which is designed and dimensioned so that it is guaranteed to be able to move through the bend of a patient's aorta without causing problems.


Possible designs of such a bendable region 9 will be explained below.


Other parts of the internally hollow guide system 1 are also illustrated and FIGS. 1 to 4 show two operating elements 2 and 3 running through the guide system 1 as far as the cartridge unit 4, and in this instance the operating element 2 likewise runs through the internally hollow operating element 3 as far as the cartridge unit 4.


The operating elements 2 and 3 in this instance are provided in the form of lengths of compression spring, which are preferably reinforced by means of tension wire. Such tension wires make the catheter safer as it is being removed from the patient's body once the operation is complete.


Other parts 11 of the guide system 1 are illustrated on the left-hand side, which may be provided in the form of more or fewer sleeve-shaped parts, although these must be secured so that they are sufficiently pressure- and tension-resistant to withstand introduction into the aorta and extraction from the aorta again. Appropriately stiff plastic hoses may be used for this purpose, for example PTFE hoses or hoses with a PTFE base, because they are sufficiently compatible with the organism and can also be sterilised.



FIG. 2 illustrates the procedure which takes place during a first stage of the operation on reaching the implantation site on the respective patient's heart. The part/sleeve-shaped element 7 of the cartridge unit 4 can be pulled back in the distal direction by a distal movement of one of the operating elements 2 and/or 3 so that some hoops 100 of the anchoring support 10, for example and preferably the support hoops provided on the known heart valve prosthesis disclosed in WO 2004/019825 A1, expand and are biased radially outwards.


The entire catheter with the guide system 1 and the cartridge unit 4 can therefore be pushed proximally and these hoops (support hoops) introduced into the pockets of the patient's old heart valve. When the surgeon feels a perceptible resistance, the process of introducing the support hoops of the anchoring support 10 into the pockets of the old heart valve is complete.


The part/sleeve-shaped element 5 of the cartridge unit 4 can then be moved proximally forwards, so that other hoops of the anchoring support can then also be released so that they can self-expand and open up the heart valve prosthesis.


A preliminary stage of this is illustrated in FIG. 3, where a heart valve prosthesis has not yet been fully unfolded and the anchoring support 10 can also not yet be fully anchored.


As also illustrated in FIG. 3, a distal part of the anchoring support 10 is still accommodated inside the cartridge unit 4, underneath the part/sleeve-shaped element 7 in the cartridge unit 4. This remains the case until the process of unfolding and positioning the heart valve prosthesis has reached the stage where its functionality can be checked.


If the check reveals incorrect functioning or faulty positioning, the part/sleeve-shaped element 7 can be pushed proximally again by one of the two operating elements 2 or 3 so that the anchoring support 10 with the heart valve prosthesis is at east partially accommodated in the cartridge unit 4 again and then the entire catheter can be removed from the patient by pulling it out of the aorta without causing damage to the vessel wall.


If the function test reveals that the heart valve prosthesis is able to fulfil its function to at least a sufficient capacity, the part/sleeve-shaped element 7 may be moved distally back, as illustrated in FIG. 4, or another part/sleeve-shaped element 6 of the cartridge unit 4 may be pushed in the proximal direction so that the distal part of the anchoring support 10 can also be released and expand fully.


As also illustrated in FIG. 4, eyes 101 or other appropriate elements are provided at distal end regions of the anchoring support 10, which were previously engaged in anchoring elements 8 provided on the part/sleeve-shaped element 6. These eyes and the anchoring elements 8 ensure reliable retraction or extraction if it is established that an anchoring support 10 incorporating a heart valve prosthesis has been incorrectly or badly implanted, enabling the anchoring support 10 and heart valve prosthesis to be removed from the patient's body.


By means of the anchoring elements 8 as well as other guide elements 16 which may optionally be provided on the part/sleeve-shaped element 6 of the cartridge unit 4, it is also possible to effect a radial turning movement to enable the hoops of an anchoring support 10 to be introduced into the pockets of an old heart valve prosthesis in an exactly correct angular position, for example, in which case the entire catheter can be turned slightly about its longitudinal axis by the surgeon during the implantation.


Detail A of FIG. 4 also specifically illustrates a cannula 12, which is fed through the cartridge unit 4 along its longitudinal axis. By mans of the cannula 4, the guide wire described in the general part of the description can be fed through cartridge unit 4.



FIG. 5 illustrates an example of a catheter with an additional manipulating part 13, on which other control elements are provided in order to permit manipulation.


The guide system 1 together with the cartridge unit 4 described above with reference to FIGS. 1 to 4 are also used in this example.


However, detail A illustrates one possible design of the bendable region 9 in the form of a link chain.


The individual links 9.1 are generally of the same shape and dimension.


In this respect, the oppositely lying end faces of the individual links 9.1 are shaped so as to form individual joints 9.2, each of which positively engages in adjacent individual links 9.1 and as a result of gaps with a sufficient gap width between the individual links 9.1 respectively ensure that the bendable region bends about at least 1800 as mentioned above, with a radius of approximately 50 mm.


The individual joints 9.2 are formed by a cut-out in the respective oppositely lying end faces of the individual links 9.1, whereby a co-operating cut-out on one end face and a co-operating rounded, complementary protruding area on the diametrically opposite end face of the individual links 9.1 form the individual joints 9.2 on respective adjacent individual links 9.1.


Although not illustrated, the bendable region 9 may be enclosed by a plastic hose to render it fluid-tight.



FIG. 5 also illustrates how a manipulating part 13 may be provided to enable a catheter proposed by the invention to be introduced and manipulated.


A handle 13.1 is provided for introducing and extracting the catheter with the guide system 1 and cartridge unit 4.


A fluid-tight closure in the form of a plate 17 is provided in the proximal part of the manipulating part 13, enabling the guide system 1 to be flange-mounted by means of a locking nut 23, and seal elements are provided, although these are not illustrated here.


A standard Luer connection 30 is also provided, by means of which the coolant liquid can be circulated.


The respective curvature of the bendable region 9 can be obtained using the handle 19, which can be turned about an axis by means of tension cables (not illustrated) and this will be further explained with the description of FIG. 6.


The entire manipulating part 13 should be sealed with respect to the surrounding environment and with respect to the guide system 1 so that it is as far as possible fluid-tight and also gas-tight if necessary.


The tube 28 can be moved laterally in the proximal direction by means of the lever 20 acting on the handle 13.1, and the corresponding movement and resultant traction or compression force transmitted to one of the two operating elements 2 and/or 3, thereby enabling a manipulation of the individual parts/sleeve-shaped elements 5, 6 and/or 7 of the cartridge unit 4 in the manner described above, for example in finely measured doses via the pumping movements of the lever 20.


The pushing handle 25 enables the position of part 5 of the cartridge unit 4 to be manipulated relative to the sleeve-shaped part 6 of the cartridge unit 4 in the extension beyond the length of spring by means of the fixing hooks, serving as anchoring elements 8. The pushing handle 25 is latched in a thread-shaped toothing 28.1 of a tube 28 by means of a compression spring. As a result, the pushing handle 25 follows the proximal movement of the tube 28, which is connected to part 6 of the cartridge via the length of spring serving as an operating element 3.


On reaching an end stop marking the first discharge stage, the pushing handle 25 can be turned in order to effect a finely measured axial displacement of part 5 of the cartridge unit 4 relative to part 6 of the cartridge unit 4 in the direction of the pitch of the thread 28.1.


With respect to operating the pushing handle 25, the latter is able to move the part 5 of the cartridge unit 4 illustrated here without an additional fine adjustment.


Such a manipulation enables the anchoring support 10 to be released (see FIG. 3) and in this position, the anchoring support 10 can still be retracted.


When the stop 29 is released by means of an actuator member 31 provided in the form of an adjusting screw for example, the cartridge unit 4 may be extracted farther by operating the lever system 20 in the manner described above until the retaining eyes of the anchoring support 10 have moved away from the cartridge unit 4 and the anchoring support 10 is able to spring away from the anchoring elements 8 due to its expansion forces.


The elements of the cartridge unit 4 may be pulled back in stages. This being the case, part 5 of the cartridge unit 4 may be retracted by pulling back the pushing handle 25 (pushing element latched) beyond part 6 of the cartridge unit 4.


By operating a releasing bolt 32, part 6 of the cartridge unit 4 connected to the tube 28 can also be returned to its initial position by pulling the pushing handle 25 farther back so that the cartridge unit 4 is then completely closed again. In this state, the catheter can be removed from the patient's body again.



FIG. 6 is an exploded diagram providing a more detailed illustration of the manipulating part 13 used in this example.


As illustrated, when the handwheel 19 is turned via the shaft 14, two toothed racks 24 oriented parallel with one another can be displaced. Accordingly, one toothed rack 24 is moved in the proximal direction as the toothed rack 24 oriented parallel with it is moved in the distal direction.


Although these are not illustrated here, tension cables may be secured to clamping jaws 21 acting on the co-operating toothed racks 24, which are fed through the internally hollow guide system 1 as far as the bendable region 9 and are preferably secured in its proximal region.


By turning the handwheel 19 accordingly, a traction force can be applied to at least one of the two tension cables, causing the bendable region 9 to assume the appropriate curvature in measured doses so that the guide system 1 can be fed through the bend of the aorta in a defined manner together with the cartridge unit 4.


As also illustrated in FIG. 6, the lever 20 connected to the handle 13.1 acts via fine toothing 28.1 on the tube 28, enabling it to be manipulated via the operating elements 2 and/or 3 to permit the sequential release of the anchoring support 10.

Claims
  • 1. Catheter for the transvascular implantation of a valve prosthesis having a prosthetic valve attached to a support element, comprising: a cartridge unit holding the valve prosthesis in a collapsed state, the valve prosthesis comprising a first plurality of support hoops with attachment elements on end regions of the support hoops, the cartridge unit comprising a first sleeve-shaped element including anchoring elements on a distal region, wherein the attachment elements engage the anchoring elements, a second sleeve-shaped element, and a third sleeve-shaped element configured to at least partially surround the valve prosthesis such that the support hoops are radially inward of the third sleeve-shaped element; andoperating elements disposed within a hollow guide system and extending to the cartridge unit, wherein the operating elements are configured to affect movement of the cartridge unit rotatably about its longitudinal axis to affect movement of the valve prosthesis rotatably and axially along its longitudinal axis;wherein axial movement between the second and third sleeve-shaped elements in substantially opposite directions is configured to affect a sequential release of the valve prosthesis from a collapsed state to an expanded state.
  • 2. Catheter as claimed in claim 1, further including a bendable region.
  • 3. Catheter as claimed in claim 2, wherein the bendable region includes a plurality of joints and is configured to affect a bend in the catheter of 180 degrees.
  • 4. Catheter as claimed in claim 1, wherein the catheter is configured such that a liquid coolant is circulated through an interior of the hollow guide system as far as the cartridge unit.
  • 5. Catheter as claimed in claim 4, wherein the hollow guide system is configured to be liquid-proof.
  • 6. Catheter as claimed in claim 1, wherein the second and third sleeve-shaped elements are telescopically disposed with respect to one another, and wherein the valve prosthesis is held in the collapsed state by the first and second sleeve-shaped elements.
  • 7. Catheter as claimed in claim 6, wherein the third sleeve-shaped element is movable in a distal direction to permit the first plurality of support hoops to self-expand while the second sleeve-shaped element maintains the remainder of the valve prosthesis in the collapsed state.
  • 8. Catheter as claimed in claim 7, wherein the second sleeve-shaped element is movable in a proximal direction to permit the remainder of the valve prosthesis to self-expand.
  • 9. Catheter as claimed in claim 1, wherein the plurality of anchoring elements are configured to permit rotation of the support element about a longitudinal axis of the catheter.
  • 10. Catheter as claimed in claim 1, wherein the first plurality of support hoops are configured to be positioned within a plurality of pockets of a native valve.
  • 11. Catheter as claimed in claim 1, wherein the valve prosthesis further includes a body portion, and the first plurality of support hoops and the body portion are configured to clamp at least a portion of native valve leaflets when the valve prosthesis is implanted.
  • 12. A catheter for implanting a valve prosthesis, comprising: a cartridge unit configured to hold the valve prosthesis in a collapsed state, the valve prosthesis comprising a plurality of support hoops with attachment elements on end regions of the support hoops, the cartridge unit comprising:a first sleeved-shaped element comprising anchoring elements on a distal region, wherein the attachment elements engage the anchoring elements;a second sleeve-shaped element; anda third sleeve-shaped element configured to at least partially surround the valve prosthesis such that the plurality of support hoops are radially inward of the third sleeve-shaped element;wherein relative axial movement between the second and third sleeve-shaped elements in substantially opposite directions is configured to permit sequential expansion of the valve prosthesis from a collapsed form to an expanded form.
  • 13. The catheter of claim 12, wherein axial movement of the third sleeve-shaped element in a distal direction relative to the first sleeve-shaped element permits the plurality of support hoops to radially expand from the collapsed form to the expanded form.
  • 14. The catheter of claim 13, wherein axial movement of the second sleeve-shaped element in a proximal direction relative to the first sleeve-shaped element permits a body portion of the valve prosthesis to radially expand from the collapsed form to a partially expanded form.
  • 15. The catheter of claim 14, wherein axial movement of the third sleeve-shaped element in the proximal direction relative to the first sleeve-shaped element collapses the plurality of support hoops.
  • 16. The catheter of claim 14, wherein further axial movement of the third sleeve-shaped element in the distal direction relative to the first sleeve-shaped element permits the plurality of attachment elements to expand.
  • 17. The catheter of claim 14, wherein relative axial movement of the first sleeve-shaped element in the proximal direction relative to the third sleeve-shaped element permits the plurality of attachment elements to expand.
  • 18. The catheter of claim 12, wherein the first sleeve-shaped element and the valve prosthesis are configured to rotate about a longitudinal axis.
  • 19. Catheter as claimed in claim 12, wherein the plurality of support hoops are configured to be positioned within a plurality of pockets of a native valve.
  • 20. The catheter of claim 12, wherein the valve prosthesis further includes a body portion, and the plurality of support hoops and the body portion are configured to clamp at least a portion of native valve leaflets when the valve prosthesis is implanted.
  • 21. A catheter for implanting a valve prosthesis including a support element and a prosthetic valve attached to the support element, comprising: a cartridge unit disposed between proximal and distal ends of the catheter configured to selectively retain the valve prosthesis in a collapsed form, the valve prosthesis comprising:a distal end, a proximal end, and a plurality of support hoops extending from the distal end of the support element toward the proximal end of the support element, the support hoops having attachment elements on end regions of the support hoops;the cartridge unit comprising:a first sleeve-shaped element comprising anchoring elements on a distal region, wherein the attachment elements engage the anchoring elements, a second sleeve-shaped element, and a third sleeve-shaped element configured to at least partially surround the valve prosthesis such that the plurality of support hoops are radially inward of the third sleeve-shaped element, wherein axial movement of the second and third sleeve-shaped elements in substantially opposite directions is configured to permit sequential expansion of the valve prosthesis from a collapsed state to an expanded state such that the plurality of support hoops are biased radially outward and configured to be positioned on a first side of a leaflet of a native valve and a remainder of the valve prosthesis is biased radially outward and configured to be positioned on a second side of the leaflet of the native valve, opposite the first side.
  • 22. The catheter of claim 21, wherein the first sleeve-shaped element is configured to affect rotation of the valve prosthesis about a longitudinal axis of the cartridge unit.
  • 23. The catheter of claim 21, wherein the cartridge unit is further configured to affect expansion of the remainder of the valve prosthesis after expansion of the plurality of support hoops.
  • 24. The catheter of claim 21, wherein the expanded plurality of support hoops and the fully expanded remainder of the valve prosthesis are configured to clamp at least a portion of the native heart valve.
  • 25. A catheter for implanting a valve prosthesis including a prosthetic valve attached to a support structure having a body portion and a plurality of support hoops with attachment elements on end regions of the support hoops, the catheter comprising: a first sleeve-shaped element comprising anchoring elements on a distal region, wherein the attachment elements engage the anchoring elements;a second sleeve-shaped element; anda third sleeve-shaped element configured to at least partially surround the valve prosthesis such that the support hoops are radially inward of the third sleeve-shaped element;wherein the is plurality of support hoops are connected to the body portion at a distal end of the body portion and extend toward a proximal end of the body portion; andwherein axial movement of the second and third sleeve-shaped elements in substantially opposite directions is configured to permit sequential expansion of the valve prosthesis from a collapsed state to an expanded state.
  • 26. The catheter of claim 25, wherein the expanded support hoops are configured to be positioned in pockets of a native heart valve.
  • 27. The catheter of claim 25, wherein the expanded plurality of support hoops and the expanded body portion are configured to clamp a native valve.
  • 28. A catheter for transvascular implantation of a valve prosthesis including a self-expanding anchoring support having a body portion and a plurality of support hoops and a prosthetic valve attached to the anchoring support with attachment elements on end regions of the support hoops, the catheter comprising: (a) a cartridge unit for carrying the anchoring support and prosthesis and having a flexible tip at its proximal end, the cartridge unit comprising a first sleeve-shaped element including anchoring elements on a distal region, wherein the attachment elements engage the anchoring elements, a second sleeve-shaped element, and a third sleeve-shaped element configured to at least partially surround the valve prosthesis such that the support hoops are radially inward of the third sleeve-shaped element, wherein axial movement of the second and third sleeve-shaped elements in substantially opposite directions is configured to permit sequential expansion of the valve prosthesis from a collapsed state to an expanded state;(b) a hollow guide system releasably connected to the cartridge unit at a proximal end of the hollow guide system; and(c) a manipulating part attached to a distal end of the hollow guide system wherein operating elements are attached at one end to the manipulating part and at the other end to the cartridge unit, the hollow guide system has a bendable region at its proximal end adjacent to the cartridge unit, the hollow guide system is configured to contain a circulating coolant or pharmaceutical preparation; and the guide system is substantially liquid proof.
  • 29. Catheter as claimed in claim 28, wherein the bendable region includes a link chain with individual joints.
  • 30. Catheter as claimed in claim 29, wherein the individual joints positively engage respectively in adjacent links.
  • 31. Catheter as claimed in claim 28, wherein the operating elements include tension wires.
  • 32. Catheter as claimed in claim 28, wherein the guide system is configured to circulate the liquid coolant through an interior of the guide system to the cartridge unit.
  • 33. Catheter as claimed in claim 28, wherein the second and third sleeve-shaped elements are telescopically engaging in one another, between which the valve prosthesis is enclosed and clamped in the collapsed state until implantation.
  • 34. Catheter as claimed in claim 28, wherein the catheter is configured for guiding a guide wire through an interior of the catheter.
Priority Claims (1)
Number Date Country Kind
10 2005 003 632 Jan 2005 DE national
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/DE2006/000056 1/12/2006 WO 00 6/5/2008
Publishing Document Publishing Date Country Kind
WO2006/076890 7/27/2006 WO A
US Referenced Citations (267)
Number Name Date Kind
4922905 Strecker May 1990 A
5002566 Carpentier et al. Mar 1991 A
5061277 Carpentier et al. Oct 1991 A
5094661 Levy et al. Mar 1992 A
5104407 Lam et al. Apr 1992 A
5197979 Quintero et al. Mar 1993 A
5279612 Eberhardt Jan 1994 A
5332402 Teitelbaum Jul 1994 A
5336258 Quintero et al. Aug 1994 A
5352240 Ross Oct 1994 A
5368608 Levy et al. Nov 1994 A
5411552 Andersen et al. May 1995 A
5456713 Chuter Oct 1995 A
5509930 Love Apr 1996 A
5549666 Hata et al. Aug 1996 A
5595571 Jaffe et al. Jan 1997 A
5613982 Goldstein Mar 1997 A
5632778 Goldstein May 1997 A
5674298 Levy et al. Oct 1997 A
5679112 Levy et al. Oct 1997 A
5683451 Lenker et al. Nov 1997 A
5697972 Kim et al. Dec 1997 A
5713953 Vallana et al. Feb 1998 A
5746775 Levy et al. May 1998 A
5755777 Chuter May 1998 A
5824041 Lenker et al. Oct 1998 A
5824080 Lamuraglia Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5841382 Walden et al. Nov 1998 A
5843181 Jaffe et al. Dec 1998 A
5876434 Flomenblit et al. Mar 1999 A
5880242 Hu et al. Mar 1999 A
5885238 Stevens et al. Mar 1999 A
5899936 Goldstein May 1999 A
5928281 Huynh et al. Jul 1999 A
5935163 Gabbay Aug 1999 A
5104407 Lam et al. Sep 1999 B1
6001126 Nguyen-Thien-Nhon Dec 1999 A
5061277 Carpentier et al. Feb 2000 B1
6077297 Robinson et al. Jun 2000 A
6093530 McIlroy et al. Jul 2000 A
6102944 Huynh et al. Aug 2000 A
6117169 Moe Sep 2000 A
6126685 Lenker et al. Oct 2000 A
6168614 Andersen et al. Jan 2001 B1
6177514 Pathak et al. Jan 2001 B1
6183481 Lee et al. Feb 2001 B1
6200336 Pavcnik et al. Mar 2001 B1
6214055 Simionescu et al. Apr 2001 B1
6231602 Carpentier et al. May 2001 B1
6254564 Wilk et al. Jul 2001 B1
6254636 Peredo Jul 2001 B1
6273876 Klima et al. Aug 2001 B1
6283995 Moe et al. Sep 2001 B1
6287338 Sarnowski et al. Sep 2001 B1
6338740 Carpentier Jan 2002 B1
6342070 Nguyen-Thien-Nhon Jan 2002 B1
6344044 Fulkerson et al. Feb 2002 B1
6350278 Lenker et al. Feb 2002 B1
6379740 Rinaldi et al. Apr 2002 B1
6391538 Vyavahare et al. May 2002 B1
6425916 Garrison et al. Jul 2002 B1
6454799 Schreck Sep 2002 B1
6471723 Ashworth et al. Oct 2002 B1
6478819 Moe Nov 2002 B2
6508833 Pavcnik et al. Jan 2003 B2
6509145 Torrianni Jan 2003 B1
6521179 Girardot et al. Feb 2003 B1
6540782 Snyders Apr 2003 B1
6558417 Peredo May 2003 B2
6558418 Carpentier et al. May 2003 B2
6572642 Rinaldi et al. Jun 2003 B2
6582462 Andersen et al. Jun 2003 B1
6585766 Huynh et al. Jul 2003 B1
6613086 Moe et al. Sep 2003 B1
6682559 Myers et al. Jan 2004 B2
6730118 Spenser et al. May 2004 B2
6736845 Marquez et al. May 2004 B2
6767362 Schreck Jul 2004 B2
6790230 Beyersdorf et al. Sep 2004 B2
6808529 Fulkerson Oct 2004 B2
6821211 Otten et al. Nov 2004 B2
6821297 Snyders Nov 2004 B2
6824970 Vyavahare et al. Nov 2004 B2
6830584 Seguin Dec 2004 B1
6861211 Levy et al. Mar 2005 B2
6872226 Cali et al. Mar 2005 B2
6881199 Wilk et al. Apr 2005 B2
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6911043 Myers et al. Jun 2005 B2
6945997 Huynh et al. Sep 2005 B2
6974474 Pavcnik et al. Dec 2005 B2
7014655 Barbarash et al. Mar 2006 B2
7018406 Seguin et al. Mar 2006 B2
7037333 Myers et al. May 2006 B2
7050276 Nishiyama May 2006 B2
7078163 Torrianni Jul 2006 B2
7081132 Cook et al. Jul 2006 B2
7137184 Schreck et al. Nov 2006 B2
7141064 Scott et al. Nov 2006 B2
7163556 Xie et al. Jan 2007 B2
7189259 Simionescu et al. Mar 2007 B2
7198646 Figulla et al. Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7238200 Lee et al. Jul 2007 B2
7252682 Seguin Aug 2007 B2
7318278 Zhang et al. Jan 2008 B2
7318998 Goldstein et al. Jan 2008 B2
7322932 Xie et al. Jan 2008 B2
7329278 Seguin et al. Feb 2008 B2
7381218 Schreck Jun 2008 B2
7393360 Spenser et al. Jul 2008 B2
7399315 Iobbi Jul 2008 B2
7452371 Pavcnik et al. Nov 2008 B2
7473275 Marquez Jan 2009 B2
20010011187 Pavcnik et al. Aug 2001 A1
20010039450 Pavcnik et al. Nov 2001 A1
20020032481 Gabbay Mar 2002 A1
20020055775 Carpentier et al. May 2002 A1
20020120322 Thompson et al. Aug 2002 A1
20020123790 White et al. Sep 2002 A1
20020133226 Marquez et al. Sep 2002 A1
20020198594 Schreck Dec 2002 A1
20030027332 Lafrance et al. Feb 2003 A1
20030036791 Philipp et al. Feb 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030050694 Yang et al. Mar 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030065386 Weadock Apr 2003 A1
20030114913 Spenser et al. Jun 2003 A1
20030125795 Pavcnik et al. Jul 2003 A1
20030139796 Sequin et al. Jul 2003 A1
20030139803 Sequin et al. Jul 2003 A1
20030149476 Damm et al. Aug 2003 A1
20030153974 Spenser et al. Aug 2003 A1
20030195620 Huynh et al. Oct 2003 A1
20030236570 Cook et al. Dec 2003 A1
20040006380 Buck et al. Jan 2004 A1
20040039436 Spenser et al. Feb 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040049262 Obermiller et al. Mar 2004 A1
20040073289 Hartley et al. Apr 2004 A1
20040078950 Schreck et al. Apr 2004 A1
20040093063 Wright et al. May 2004 A1
20040117004 Osborne et al. Jun 2004 A1
20040117009 Cali et al. Jun 2004 A1
20040148018 Carpentier et al. Jul 2004 A1
20040153145 Simionescu et al. Aug 2004 A1
20040186558 Pavcnik et al. Sep 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040193244 Hartley et al. Sep 2004 A1
20040210301 Obermiller Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040243143 Corcoran et al. Dec 2004 A1
20040260389 Case et al. Dec 2004 A1
20050009000 Wilhelm et al. Jan 2005 A1
20050033220 Wilk et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050049692 Numamoto et al. Mar 2005 A1
20050075725 Rowe Apr 2005 A1
20050075776 Cho Apr 2005 A1
20050096726 Sequin et al. May 2005 A1
20050096736 Osse et al. May 2005 A1
20050098547 Cali et al. May 2005 A1
20050113910 Paniagua et al. May 2005 A1
20050119728 Sarac Jun 2005 A1
20050119736 Zilla et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137697 Salahieh et al. Jun 2005 A1
20050137698 Salahieh et al. Jun 2005 A1
20050137702 Haug et al. Jun 2005 A1
20050143804 Haverkost Jun 2005 A1
20050143807 Pavcnik et al. Jun 2005 A1
20050149166 Schaeffer et al. Jul 2005 A1
20050150775 Zhang et al. Jul 2005 A1
20050171597 Boatman et al. Aug 2005 A1
20050171598 Schaeffer Aug 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050197695 Stacchino et al. Sep 2005 A1
20050222668 Schaeffer et al. Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050267560 Bates Dec 2005 A1
20060009842 Huynh et al. Jan 2006 A1
20060025857 Bergheim et al. Feb 2006 A1
20060047343 Oviatt et al. Mar 2006 A1
20060058864 Schaeffer et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060111770 Pavcnik et al. May 2006 A1
20060142846 Pavcnik et al. Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060155366 LaDuca et al. Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060193885 Neethling et al. Aug 2006 A1
20060210597 Hiles Sep 2006 A1
20060224183 Freudenthal Oct 2006 A1
20060229718 Marquez Oct 2006 A1
20060229719 Marquez et al. Oct 2006 A1
20060246584 Covelli Nov 2006 A1
20060259134 Schwammenthal et al. Nov 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060265056 Nguyen et al. Nov 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20060290027 O'Connor et al. Dec 2006 A1
20060293745 Carpentier et al. Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070005131 Taylor Jan 2007 A1
20070005132 Simionescu et al. Jan 2007 A1
20070020248 Everaerts et al. Jan 2007 A1
20070021826 Case et al. Jan 2007 A1
20070027535 Purdy, Jr. et al. Feb 2007 A1
20070038291 Case et al. Feb 2007 A1
20070038295 Case et al. Feb 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070050014 Johnson Mar 2007 A1
20070088431 Bourang et al. Apr 2007 A1
20070093887 Case et al. Apr 2007 A1
20070100435 Case et al. May 2007 A1
20070100440 Figulla et al. May 2007 A1
20070112422 Dehdashtian May 2007 A1
20070123700 Ueda et al. May 2007 A1
20070123979 Perier et al. May 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070162103 Case et al. Jul 2007 A1
20070173932 Cali et al. Jul 2007 A1
20070179592 Schaeffer Aug 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070203576 Lee et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070239271 Nguyen Oct 2007 A1
20070244551 Stobie Oct 2007 A1
20070260327 Case et al. Nov 2007 A1
20070288087 Fearnot et al. Dec 2007 A1
20080004688 Spenser et al. Jan 2008 A1
20080021546 Patz et al. Jan 2008 A1
20080033534 Cook et al. Feb 2008 A1
20080065011 Marchand et al. Mar 2008 A1
20080071361 Tuval et al. Mar 2008 A1
20080071362 Tuval et al. Mar 2008 A1
20080071363 Tuval et al. Mar 2008 A1
20080071366 Tuval et al. Mar 2008 A1
20080071368 Tuval et al. Mar 2008 A1
20080071369 Tuval et al. Mar 2008 A1
20080077236 Letac et al. Mar 2008 A1
20080086205 Gordy et al. Apr 2008 A1
20080097586 Pavcnik et al. Apr 2008 A1
20080102439 Tian et al. May 2008 A1
20080133003 Seguin et al. Jun 2008 A1
20080140189 Nguyen et al. Jun 2008 A1
20080154355 Benichou et al. Jun 2008 A1
20080200977 Paul et al. Aug 2008 A1
20080215143 Seguin Sep 2008 A1
20080255660 Guyenot et al. Oct 2008 A1
20080262602 Wilk et al. Oct 2008 A1
20080269878 Iobbi Oct 2008 A1
20080275549 Rowe Nov 2008 A1
20090222076 Figulla et al. Sep 2009 A1
20100249915 Zhang Sep 2010 A1
20100249916 Zhang Sep 2010 A1
20100249917 Zhang Sep 2010 A1
20100249918 Zhang Sep 2010 A1
Foreign Referenced Citations (200)
Number Date Country
2006310681 May 2007 AU
2436258 Jan 2005 CA
2595233 Jul 2006 CA
2627555 May 2007 CA
195 46 692 Jun 1997 DE
19546692 Jun 1997 DE
20003874 Jun 2000 DE
19857887 Jul 2000 DE
10010073 Sep 2001 DE
10010074 Oct 2001 DE
100 34 105 Apr 2002 DE
101 21 210 Nov 2002 DE
19546692 Nov 2002 DE
10301026 Feb 2004 DE
10335948 Jul 2004 DE
10302447 Feb 2005 DE
10010074 Apr 2005 DE
19857887 May 2005 DE
10010073 Dec 2005 DE
10 2005 051 849 May 2007 DE
10 2005 052628 May 2007 DE
202007005491 Jul 2007 DE
0084395 Jul 1983 EP
0458877 Aug 1990 EP
0402036 Dec 1990 EP
0402176 Dec 1990 EP
0 411 118 Feb 1991 EP
0458877 Apr 1991 EP
0515324 Nov 1992 EP
0547135 Jun 1993 EP
0 657 147 Jun 1995 EP
0871414 Sep 1995 EP
0 592 410 Oct 1995 EP
0756498 Oct 1995 EP
0 592 410 Nov 1995 EP
0786970 May 1996 EP
0729364 Sep 1996 EP
0756498 May 1997 EP
0778775 Jun 1997 EP
0786970 Aug 1997 EP
0888142 Sep 1997 EP
0971649 Oct 1998 EP
0928615 Jul 1999 EP
1051204 Jul 1999 EP
1089676 Dec 1999 EP
0986348 Mar 2000 EP
1117446 Apr 2000 EP
1 164 976 Aug 2000 EP
1158937 Sep 2000 EP
1 251 805 Oct 2000 EP
1041942 Oct 2000 EP
1041943 Oct 2000 EP
1171061 Oct 2000 EP
1206179 Feb 2001 EP
1 233 731 May 2001 EP
1117446 Jul 2001 EP
1 255 510 Aug 2001 EP
1259193 Sep 2001 EP
1 233 731 May 2002 EP
1 330 213 May 2002 EP
1206179 May 2002 EP
1347785 Aug 2002 EP
1235537 Sep 2002 EP
1248655 Oct 2002 EP
1251804 Oct 2002 EP
1257305 Nov 2002 EP
0 971 649 Dec 2002 EP
1395208 Dec 2002 EP
1 401 359 Jan 2003 EP
1406561 Jan 2003 EP
1281357 Feb 2003 EP
1281375 Feb 2003 EP
1408882 Feb 2003 EP
1 435 878 Apr 2003 EP
1 435 879 Apr 2003 EP
1 441 672 Jun 2003 EP
1 017 868 Sep 2003 EP
1354569 Oct 2003 EP
1494616 Oct 2003 EP
1 519 697 Jan 2004 EP
1 539 047 Apr 2004 EP
1551274 Apr 2004 EP
1 560 542 May 2004 EP
1414295 May 2004 EP
1 603 493 Sep 2004 EP
1452153 Sep 2004 EP
0987998 Oct 2004 EP
1 087 727 Nov 2004 EP
1499366 Jan 2005 EP
1 663 070 Mar 2005 EP
1 253 875 Apr 2005 EP
1 667 614 Apr 2005 EP
1 251 803 Jun 2005 EP
1 702 247 Jul 2005 EP
1734902 Aug 2005 EP
1469797 Nov 2005 EP
1835948 Jun 2006 EP
1863545 Sep 2006 EP
1893132 Nov 2006 EP
1901681 Dec 2006 EP
1 255 510 Mar 2007 EP
1835948 Sep 2007 EP
1112042 Nov 2007 EP
1878407 Jan 2008 EP
1886649 Feb 2008 EP
1 900 343 Mar 2008 EP
1259195 Oct 2008 EP
1980220 Oct 2008 EP
1994913 Nov 2008 EP
2 000 115 Dec 2008 EP
2828263 Feb 2003 FR
2433700 Jul 2007 GB
2440809 Feb 2008 GB
2003-523262 Aug 2003 JP
2003-524504 Aug 2003 JP
2005-118585 May 2005 JP
2007-296375 Nov 2007 JP
2008539305 Nov 2008 JP
WO-9009102 Aug 1990 WO
WO 9511055 Apr 1995 WO
WO-9524873 Sep 1995 WO
WO-9528183 Oct 1995 WO
WO-9613227 May 1996 WO
WO-9732615 Sep 1997 WO
WO-9843556 Oct 1998 WO
WO-9846165 Oct 1998 WO
WO-9937337 Jul 1999 WO
WO 9953987 Oct 1999 WO
WO 9953987 Oct 1999 WO
WO-9966863 Dec 1999 WO
WO 0002503 Jan 2000 WO
WO 0015148 Mar 2000 WO
WO-0018445 Apr 2000 WO
WO 0025702 May 2000 WO
WO 0047139 Aug 2000 WO
WO-0053125 Sep 2000 WO
WO-0062714 Oct 2000 WO
WO-0110209 Feb 2001 WO
WO 0135870 May 2001 WO
WO-0141679 Jun 2001 WO
WO-0151104 Jul 2001 WO
WO 0154625 Aug 2001 WO
WO-0158503 Aug 2001 WO
WO 0162189 Aug 2001 WO
WO 0164137 Sep 2001 WO
WO 0236048 May 2002 WO
WO-02058745 Aug 2002 WO
WO-02100301 Dec 2002 WO
WO-02102286 Dec 2002 WO
WO 03003949 Jan 2003 WO
WO-03007795 Jan 2003 WO
WO-03009785 Feb 2003 WO
WO 03011195 Feb 2003 WO
WO 03013239 Feb 2003 WO
WO 03028592 Apr 2003 WO
WO 03047468 Jun 2003 WO
WO 03051231 Jun 2003 WO
WO-03079928 Oct 2003 WO
WO 03096935 Nov 2003 WO
WO 2004004597 Jan 2004 WO
WO 2004016200 Feb 2004 WO
WO 2004016201 Feb 2004 WO
WO 2004019825 Mar 2004 WO
WO-2004026117 Apr 2004 WO
WO 2004026173 Apr 2004 WO
WO 2004028399 Apr 2004 WO
WO 2004043301 May 2004 WO
WO 2004082527 Sep 2004 WO
WO 2004082528 Sep 2004 WO
WO 2004096100 Nov 2004 WO
WO 2005021063 Mar 2005 WO
WO 2005034812 Apr 2005 WO
WO 2005062980 Jul 2005 WO
WO 2005063980 Jul 2005 WO
WO-2005072654 Aug 2005 WO
WO 2006066327 Jun 2006 WO
WO-2006066327 Jun 2006 WO
WO 2006076890 Jul 2006 WO
WO-2006102063 Sep 2006 WO
WO 2006108090 Oct 2006 WO
WO-2006124649 Nov 2006 WO
WO 2006124649 Nov 2006 WO
WO 2006127756 Nov 2006 WO
WO 2006127765 Nov 2006 WO
WO-2006132948 Dec 2006 WO
WO 2007047488 Apr 2007 WO
WO 2007047945 Apr 2007 WO
WO 2007051620 May 2007 WO
WO 2007059252 May 2007 WO
WO-2007071436 Jun 2007 WO
WO 2007098232 Aug 2007 WO
WO 2007120543 Oct 2007 WO
WO-2008028569 Mar 2008 WO
WO 2008045949 Apr 2008 WO
WO 2008070797 Jun 2008 WO
WO 2006076890 Jul 2008 WO
WO 2008079962 Jul 2008 WO
WO 2008101083 Aug 2008 WO
WO 2008125153 Oct 2008 WO
WO 2008138584 Nov 2008 WO
Non-Patent Literature Citations (9)
Entry
File history for German Patent DE 195 46 692 filed Dec. 14, 1995 and patented Jul. 11, 2002.
Ferrari, M. et al., “Transarterial Aortic Valve Replacement with a Self Expanding Stent in Pigs,” Heart, vol. 90, pp. 1326-1331, (2004).
Aortenklappenbioprothese erfolgreich in der Entwicklung, (1 page) May 16, 2003.
Translation of Aortenklappenbioprothese erfolgreich in der Entwicklung (2 pages).
Screen shots from http://www.fraunhofer.de/presse/filme/2006/index.jsp (2 pages), 2006.
Liang, Ma, et al., “Double-crowned valved stents for off-pump mitral valve replacement,” European Journal of Cardio-Thoracic Surgery, 194-198 (5 pages), Jun. 13, 2005.
Huber, Christoph, et al. “Direct Access Valve Replacement (DAVR)—are we entering a new era in cardiac surgery?” European Journal of Cardio-Thoracic Surgery, 380-385, (6 pages), Jan. 19, 2006.
Translation of DE 19546692 A1 (4 pages).
Translation of EP 1469797 B1 (16 pages).
Related Publications (1)
Number Date Country
20090234443 A1 Sep 2009 US